SCD1 Confers Temozolomide Resistance to Human Glioma Cells Via the Akt/GSK3β/β-Catenin Signaling Axis (vol 8, 960, 2018)

被引：4
|
作者：
Dai, Shuang [1 ,2 ,3 ]
Yan, Yuanliang [1 ,3 ]
Xu, Zhijie [1 ,3 ,4 ]
Zeng, Shuangshuang [1 ,3 ]
Qian, Long [1 ,3 ]
Huo, Lei [5 ]
Li, Xuejun [5 ]
Sun, Lunquan [6 ]
Gong, Zhicheng [1 ,3 ]
机构：
[1] Cent S Univ, Dept Pharm, Xiangya Hosp, Changsha, Hunan, Peoples R China
[2] Cent S Univ, Sch Pharmaceut Sci, Changsha, Hunan, Peoples R China
[3] Cent S Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Changsha, Hunan, Peoples R China
[4] Cent S Univ, Dept Pathol, Xiangya Hosp, Changsha, Hunan, Peoples R China
[5] Cent S Univ, Dept Neurosurg, Xiangya Hosp, Changsha, Hunan, Peoples R China
[6] Cent S Univ, Xiangya Hosp, Key Lab Mol Radiat Oncol Hunan Prov, Ctr Mol Med, Changsha, Hunan, Peoples R China
来源：
FRONTIERS IN PHARMACOLOGY | 2019年 / 10卷
关键词：
glioblastomas; temozolomide; resistance; SCD1; Akt signaling;
D O I：
10.3389/fphar.2019.01358
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] SCD1 Confers Temozolomide Resistance to Human Glioma Cells via the Akt/GSK3β/β-Catenin Signaling Axis
    Dai, Shuang
    Yan, Yuanliang
    Xu, Zhijie
    Zeng, Shuangshuang
    Qian, Long
    Huo, Lei
    Li, Xuejun
    Sun, Lunquan
    Gong, Zhicheng
    FRONTIERS IN PHARMACOLOGY, 2018, 8
  • [2] Nobiletin inhibits invasion via inhibiting AKT/GSK3β/β-catenin signaling pathway in Slug-expressing glioma cells
    Zhang, Xiang
    Zheng, Kebin
    Li, Chunhui
    Zhao, Yonghui
    Li, Heyang
    Liu, Xuguang
    Long, Yinbo
    Yao, Junchao
    ONCOLOGY REPORTS, 2017, 37 (05) : 2847 - 2856
  • [3] ACROLEIN INDUCES THE MIR-30A-5P/NCAM AXIS VIA THE AKT/GSK3Β/Β-CATENIN PATHWAY, PROMOTING GLIOMA PROGRESSION
    Chen, Pin-Yuan
    Liu, Pei-Yu
    Huang, Chiungyin
    Wang, Hsiang-Tsui
    NEURO-ONCOLOGY, 2024, 26
  • [4] Celastrol confers ferroptosis resistance via AKT/GSK3β signaling in high-fat diet-induced cardiac injury
    Bian, Jinhui
    Ding, Yi
    Wang, Song
    Jiang, Yefan
    Wang, Mingyan
    Wei, Ke
    Si, Linjie
    Zhao, Xin
    Shao, Yongfeng
    FREE RADICAL BIOLOGY AND MEDICINE, 2023, 200 : 36 - 46
  • [5] Temozolomide induces activation of Wnt/β-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy
    Tomar, Vivek Singh
    Patil, Vikas
    Somasundaram, Kumaravel
    CELL BIOLOGY AND TOXICOLOGY, 2020, 36 (03) : 273 - 278
  • [6] Temozolomide induces activation of Wnt/β-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy
    Vivek Singh Tomar
    Vikas Patil
    Kumaravel Somasundaram
    Cell Biology and Toxicology, 2020, 36 : 273 - 278
  • [7] Heat Shock Protein 90 Triggers Multi-Drug Resistance of Ovarian Cancer via AKT/GSK3β/β-Catenin Signaling
    Yin, Lan
    Yang, Yuhan
    Zhu, Wanglong
    Xian, Yu
    Han, Zhengyu
    Huang, Houyi
    Peng, Liaotian
    Zhang, Kun
    Zhao, Ye
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [8] FOXM1-mediated NUF2 expression confers temozolomide resistance to human glioma cells by regulating autophagy via the PI3K/AKT/mTOR signaling pathway
    Guo, Liang
    Wu, Zhangyi
    NEUROPATHOLOGY, 2022, 42 (05) : 430 - 446
  • [9] An Isoxazole Chalcone Derivative Enhances Melanogenesis in B16 Melanoma Cells via the Akt/GSK3/-Catenin Signaling Pathways
    Yin, Li
    Niu, Chao
    Liao, Li-xin
    Dou, Jun
    Habasi, Maidina
    Aisa, Haji Akber
    MOLECULES, 2017, 22 (12):
  • [10] MASM inhibits cancer stem cell-like characteristics of EpCAM+ cells via AKT/GSK3β/β-catenin signaling
    Sun, Keyan
    Shen, Huaxing
    He, Shipeng
    Liu, Ying
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2022, 14 (11): : 8380 - 8389
12345